TickerFacts.

Iqvia Holdings Inc. (IQV): Total Liabilities

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2017-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$23.31B
As of 2025-12-31
$23.33B
As of 2026-03-31
+6.0%
3-year compound annual growth
+5.0%
5-year compound annual growth
2012-12-31: $3.86B2013-12-31: $3.73B2014-12-31: $4.00B2015-12-31: $4.26B2016-12-31: $12.35B2017-12-31: $14.61B2018-12-31: $15.60B2019-12-31: $16.99B2020-12-31: $18.28B2021-12-31: $18.65B2022-12-31: $19.57B2023-12-31: $20.57B2024-12-31: $20.83B2025-12-31: $23.31B$23.31B
2012-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$23.31B+11.9%2026-02-17, Balance as of period end
2024-12-31$20.83B+1.3%2026-02-17, Balance as of period end
2023-12-31$20.57B+5.1%2025-02-13, Balance as of period end
2022-12-31$19.57B+5.0%2024-02-15, Balance as of period end
2021-12-31$18.65B+2.0%2023-02-15, Balance as of period end
2020-12-31$18.28B+7.6%2022-02-16, Balance as of period end
2019-12-31$16.99B+8.9%2021-02-12, Balance as of period end
2018-12-31$15.60B+6.7%2020-02-18, Balance as of period end
2017-12-31$14.61Bn/c2019-02-19, Balance as of period end
2016-12-31$12.35B+189.7%2018-02-16, Balance as of period end
2015-12-31$4.26B+6.6%2017-02-16, Balance as of period end
2014-12-31$4.00B+7.1%2016-02-11, Balance as of period end
2013-12-31$3.73B-3.2%2015-02-12, Balance as of period end
2012-12-31$3.86Bn/a2014-02-13, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Iqvia Holdings Inc. (IQV)2025-12-31$23.31B+11.9%
Icon PLC (ICLR)2025-12-31$7.08B-1.6%
Incyte Corp (INCY)2025-12-31$1.79B-10.3%
Charles River Laboratories International, Inc. (CRL)2025-12-27$3.92B-2.4%
Medpace Holdings, Inc. (MEDP)2025-12-31$1.52B+18.9%
NRC Health (NRC)2025-12-31$120.89M+19.4%
MaxCyte, Inc. (MXCT)2025-12-31$31.02M-6.6%
OmniAb, Inc. (OABI)2025-12-31$33.89M-10.7%
Foxo Technologies Inc. (FOXO)2025-12-31$33.50M-8.1%

Compare IQV, ICLR, INCY, CRL side by side · Screen every company in Services-Commercial Physical & Biological Research ↗